Patents by Inventor Paul Spencer

Paul Spencer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140080830
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: November 25, 2013
    Publication date: March 20, 2014
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr
  • Patent number: 8609657
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: December 17, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr
  • Patent number: 8586583
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: November 19, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr
  • Patent number: 8586590
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: November 19, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr
  • Patent number: 8580797
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: November 12, 2013
    Assignee: Glaxo Smith Kline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr
  • Patent number: 8575162
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: November 5, 2013
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr
  • Patent number: 8524751
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: September 3, 2013
    Assignee: GlaxoSmithKline Intellecutual Property Development
    Inventors: Julie Nicole Hamblin, Zoe Alicia Harrison, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Christopher James Lunniss, Nigel James Parr
  • Publication number: 20130205324
    Abstract: An automatic content recognition (ACR)-enabled connected TV device may be operable to present an overlay offering a coupon utilizing an ACR system, where the overlay may also be presented on a paired device. The ACR-enabled connected TV device may present information associated with a value of the coupon based on interaction with the presented overlay by the viewer. The value of the coupon may be determined based on a profile associated with the ACR-enabled connected TV device. The profile may be determined and maintained utilizing the ACR system. The viewer may obtain the coupon associated with the value information from a microsite assigned to the viewer. The viewer may share information on a link of the microsite with one or more other viewers. The value of the coupon may change when one or more of the other viewers click on the link of the microsite to obtain the coupon.
    Type: Application
    Filed: December 28, 2012
    Publication date: August 8, 2013
    Inventors: Nishith Kumar Sinha, Donald Jude Loheide, Matthew Paul Giles, Karl-Christian Sebastian Wolff-Ingham, Paul Spencer Amsbary
  • Publication number: 20130203772
    Abstract: The present invention is directed to a polymorph of a compound and salts of a compound and polymorphs thereof, which compound is an inhibitor of kinase activity.
    Type: Application
    Filed: October 25, 2011
    Publication date: August 8, 2013
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Nigel James Parr, Robert David Willacy
  • Publication number: 20130165433
    Abstract: The present invention is directed to compounds for use in the treatment or prevention of influenza virus infection.
    Type: Application
    Filed: September 6, 2011
    Publication date: June 27, 2013
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin, Zoe Alicia Harrison, Katherine Louise Jones, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Christopher James Lunniss, Charlotte Jane Mitchell, Nigel James Parr, Timothy John Ritchie, John Edward Robinson, Juliet Kay Simpson, Christopher Alan Paul Smethurst, Yoshiaki Washio
  • Publication number: 20130165441
    Abstract: The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.
    Type: Application
    Filed: September 6, 2011
    Publication date: June 27, 2013
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Julie Nicole Hamblin, Paul Spencer Jones, Suzanne Elaine Keeling, Joelle Le, Charlotte Jane Mitchell, Nigel James Parr, Robert David Willacy
  • Patent number: 8470861
    Abstract: The present invention is a mitochondria-targeted antioxidant prodrug useful for the prevention or treatment of diseases or conditions associated with mitochondrial dysfunction resulting from changes in the mitochondrial redox environment. Antioxidant prodrugs of the invention are produced by modifying an antioxidant to a fatty acid so that the resulting prodrug is targeted to and activated by an enzyme of mitochondrial fatty acid beta-oxidation.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: June 25, 2013
    Assignee: University of Rochester
    Inventors: Marion W. Anders, James L. Robotham, Shey-Shing Sheu, Paul Spencer Brookes, Jalil Shojaie, Leif Olson, Richard L. Parton
  • Patent number: 8452311
    Abstract: A method for waking up user equipment in a cellular network includes waking up a receiver module at a predetermined wakeup time to receive a transmitted paging signal, when awake, determining prevailing conditions for receiving paging signals, and skipping at least a next possible wakeup time if at least one of the prevailing conditions exceeds an associated threshold level. A user equipment for use on a mobile communications network includes a reception quality determiner to determine at least one of a reception quality of a received signal and a radio frequency (RF) level of the signal, a paging indication processor to process received paging signals, a system message handler to determine a level of activity for a cellular network, and a conditional wakeup mechanism that is configured to set a next wakeup for the user equipment time responsively to an input from at least one of the reception quality determiner and the system message handler.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: May 28, 2013
    Assignee: Marvell International Ltd.
    Inventors: Yona Leshets, Daniel Ben-Ari, Paul Spencer
  • Publication number: 20130131080
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: October 2, 2012
    Publication date: May 23, 2013
    Inventors: Julie Nicole HAMBLIN, Paul Spencer JONES, Suzanne Elaine KEELING, Joelle LE, Nigel James PARR
  • Publication number: 20130096117
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): And salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: October 2, 2012
    Publication date: April 18, 2013
    Inventors: Julie Nicole HAMBLIN, Paul Spencer JONES, Suzanne Elaine KEELING, Joelle LE, Nigel James PARR
  • Publication number: 20130029985
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: October 2, 2012
    Publication date: January 31, 2013
    Inventors: Julie Nicole HAMBLIN, Paul Spencer JONES, Suzanne Elaine KEELING, Joelle LE, Charlotte Jane MITCHELL, Nigel James PARR
  • Publication number: 20120245171
    Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): and salts thereof. The compounds of the invention are inhibitors of PI3-kinase activity.
    Type: Application
    Filed: December 3, 2010
    Publication date: September 27, 2012
    Applicant: GLAXO GROUP LIMITED
    Inventors: Ian Robert Baldwin, Kenneth David Down, Paul Faulder, Simon Gaines, Julie Nicole Hamblin, Katherine Louise Jones, Paul Spencer Jones, Joelle Le, Christopher James Lunniss, Nigel James Parr, Timothy John Ritchie, John Edward Robinson, Juliet Kay Simpson, Christian Alan Paul Smethurst
  • Publication number: 20120164373
    Abstract: A prepreg for the manufacture of a fibre-reinforced composite material, the prepreg including: i. an epoxy-resin matrix including: a. at least one non-halogenated epoxide-containing resin which has been chemically modified with at least one of a nitrogen- and/or phosphorous-containing molecule which has been chemically reacted with the epoxide-containing molecule; b. at least one toughening additive comprising an elastomeric or thermoplastic material chemically reacted with the at least one epoxide-containing resin; c. at least one mineral filler to provide fire-retardancy; and d. at least one catalyst for curing the epoxide-containing resin; and ii. a fibrous reinforcement at least partially impregnated by the epoxy resin matrix.
    Type: Application
    Filed: August 5, 2010
    Publication date: June 28, 2012
    Applicant: Gurit (UK) Ltd.
    Inventors: Paul Spencer, Benjamin Creaser
  • Publication number: 20120145978
    Abstract: An adjustable lift truck having a frame with a first end and an opposing second end. The frame defines a longitudinal axis that extends from the first end to the second end. A pair of transport wheels are rotatably mounted to the frame proximate the first end. A pair of laterally spaced-apart outriggers extend generally perpendicularly to the longitudinal axis of the frame. Each outrigger is located proximate the first end of the frame, and includes a first end pivotally attached to the frame and an opposing free second end.
    Type: Application
    Filed: December 13, 2011
    Publication date: June 14, 2012
    Applicant: WESCO INDUSTRIAL PRODUCTS, INC.
    Inventors: Steve RICH, Paul SPENCER, Jeff Carson JARRELL, Ronald David MELVIN, Rob LEVINS
  • Patent number: 8194769
    Abstract: Embodiments of a GERAN transceiver for communicating in a global system for mobile communications (GSM) enhanced data rates for GSM evolution (EDGE) radio access network (GERAN) are described herein. The GERAN transceiver includes a codation module to split a turbo-encoded data block into a plurality of turbo-encoded data bursts and to interleave the plurality of turbo-encoded data bursts for individual transmission on across a plurality of tonal carriers corresponding to independent GERAN frequency channels.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: June 5, 2012
    Assignee: Intel Corporation
    Inventor: Paul Spencer